4//SEC Filing
Kopczynski Casey C. 4
Accession 0001209191-20-058021
CIK 0001337553other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 5:03 PM ET
Size
6.9 KB
Accession
0001209191-20-058021
Insider Transaction Report
Form 4
Kopczynski Casey C.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2020-11-11$13.01/sh−22,695$295,210→ 196,114 total - Sale
Common Stock
2020-11-10$13.00/sh−7,305$94,965→ 218,809 total
Footnotes (2)
- [F1]Following the sales reported on this Form 4, the reporting person's Rule 10b5-1 plan dated May 15, 2020 is completed.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.03, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
AERIE PHARMACEUTICALS INC
CIK 0001337553
Entity typeother
Related Parties
1- filerCIK 0001590001
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 5:03 PM ET
- Size
- 6.9 KB